COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders

Am J Clin Pathol. 2006 Nov;126(5):717-24. doi: 10.1309/PFGX-CLNG-2N17-PJX9.

Abstract

Idiopathic usual interstitial pneumonia/idiopathic pulmonary fibrosis (UIP/IPF) and asbestosis represent progressive and often fatal pulmonary fibrous disorders, whereas cryptogenic organizing pneumonia (COP), desquamative interstitial pneumonia (DIP), and respiratory bronchiolitis-interstitial lung disease (RB-ILD) usually are reversible or nonprogressive conditions. Prostaglandin E2 (PGE2) inhibits fibroblast proliferation and myofibroblast transition, its production depending on cyclooxygenase-2 (COX-2). In patients with UIP/IPF, levels of PGE2 and COX-2 are reduced in fibroblasts, and levels of PGE2 in bronchioalveolar lavage fluid may be lowered. We analyzed the immunohistochemical expression of COX-2 in UIP/IPF, asbestosis, COP, DIP, and RB-ILD. Our results show that the metaplastic epithelium in UIP/IPF, asbestosis, and COP is widely COX-2+, whereas COX-2 positivity is scant in DIP and RB-ILD. The mesenchymal cells remained negative. Our results suggest that irrespective of the underlying disease, lung injury that causes extensive fibrosis induces wide expression of COX-2 in the regenerating metaplastic epithelium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asbestosis / enzymology
  • Asbestosis / pathology
  • Bronchiolitis / enzymology
  • Bronchiolitis / pathology
  • Cryptogenic Organizing Pneumonia / enzymology
  • Cryptogenic Organizing Pneumonia / pathology
  • Cyclooxygenase 2 / metabolism*
  • Epithelium / enzymology
  • Epithelium / pathology
  • Humans
  • Immunohistochemistry
  • Lung Diseases, Interstitial / enzymology
  • Lung Diseases, Interstitial / pathology
  • Membrane Proteins / metabolism*
  • Metaplasia
  • Pulmonary Fibrosis / enzymology
  • Pulmonary Fibrosis / pathology*

Substances

  • Membrane Proteins
  • Cyclooxygenase 2
  • PTGS2 protein, human